| Adverse effects: 4. SAS ‐ short term by 12 weeks (high score=poor, skewed data) | |||||
|---|---|---|---|---|---|
| Study | Intervention | Mean | SD | N | Notes |
| Chai 1998 | Pipotiazine | 1.00 | 2.10 | 103 | |
| Chai 1998 | Control | 5.10 | 5.60 | 106 | |
| Adverse effects: 4. SAS ‐ short term by 12 weeks (high score=poor, skewed data) | |||||
|---|---|---|---|---|---|
| Study | Intervention | Mean | SD | N | Notes |
| Chai 1998 | Pipotiazine | 1.00 | 2.10 | 103 | |
| Chai 1998 | Control | 5.10 | 5.60 | 106 | |